Connect: Facebook Twitter gprofile_button-64 linkedin_in_icon_55px

Researchware, Inc.

Simply Powerful Tools for Qualitative Research

Researchware Cofounder Conducts Study on Impact of BRCA1/2 Gene on Men and Women

Researchware Cofounder and Boston College faculty member, Dr. Sharlene Hesse-Biber is conducting a study about the lived experiences and social psychological impact of the BRCA1/2 gene mutation on men and women. Despite close to 2,000 men being diagnosed with breast cancer each year, the experience of males with breast cancer is widely unknown. This is especially true for men of color,  thus contributing to a significant gap in our sociological understanding of the disease. In a study led by Dr. Sharlene Hesse-Biber, we aim to learn more about male experiences with breast cancer and the BRCA1/2 gene mutation in order to give men a chance to voice their stories. As part of this work, a Facebook page was recently launched at https://www.facebook.com/BostonCollegeBrcaStudy.

You may qualify to participate in the study if you are a male who either has:
- a family history of breast cancer and is at a high risk for the BRCA1/2 gene mutation, or
- been genetically tested for the BRCA1/2 gene mutation.
 
Please note, however, you do not need to have tested positive for the BRCA gene to qualify.

If you answered yes to either of these questions, we hope you will participate in our short confidential survey that asks about your experiences and pass this information along to others who you feel may fit the criteria to participate. Please click this link or paste it into your URL to read more about the study and take our 20-30 minute survey.
https://bostoncollegeaands.qualtrics.com/SE/?SID=SV_2meMcRSndGrMxYE

For questions or concerns, please call Dr. Hesse-Biber at 617.552.4139 or email hesse@bc.edu.

Keep In Touch!



  1. Sign up for Researchware emails and be the first to learn about exclusive offers, product upgrades, and promotions.

  2. Please enter a valid email address.
  3. Please enter your valid email address again.